Pacific Biosciences's market cap is currently ―. The company's EPS TTM is €-1.122; its P/E ratio is -2.31; Pacific Biosciences is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is €-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 55.69M	$ 47.39M	$ 38.90M	$ -68.64M	$ 32.31M
Gross Profit	$ 17.90M	$ 15.55M	$ 9.76M	$ 23.33M	$ 13.55M
EBIT	$ -73.99M	$ -66.28M	$ -84.39M	$ -96.30M	$ -73.46M
EBITDA	$ -68.86M	$ -61.25M	$ -79.71M	$ -96.12M	$ -69.15M
Net Income Common Stockholders	$ -65.39M	$ -69.83M	$ -88.02M	$ -84.38M	$ -76.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 767.79M	$ 830.16M	$ 875.19M	$ 772.62M	$ 834.34M
Total Assets	$ 1.90B	$ 1.85B	$ 1.90B	$ 1.77B	$ 1.82B
Total Debt	$ 935.56M	$ 937.64M	$ 944.83M	$ 946.64M	$ 948.30M
Net Debt	$ 167.77M	$ 107.47M	$ 69.63M	$ 174.02M	$ 113.96M
Total Liabilities	$ 1.13B	$ 1.21B	$ 1.20B	$ 1.77B	$ 1.19B
Stockholders Equity	$ 763.74M	$ 642.00M	$ 692.12M	$ 562.90M	$ 626.59M
Cash Flow	-
Free Cash Flow	$ -66.01M	$ -44.01M	$ -98.41M	$ -70.25M	$ -67.24M
Operating Cash Flow	$ -65.18M	$ -41.74M	$ -94.69M	$ -65.16M	$ -63.05M
Investing Cash Flow	$ 242.32M	$ -98.59M	$ -72.55M	$ 85.00M	$ 53.91M
Financing Cash Flow	$ -781.00K	$ -4.71M	$ 195.99M	$ 819.00K	$ 3.13M

Currency in USD

Pacific Biosciences Earnings and Revenue History

Income Statement >

Pacific Biosciences Debt to Assets

Balance Sheet >

Pacific Biosciences Cash Flow

Cash Flow >

Pacific Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing